Cytopenia Management in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Azacitidine in the VIALE-A Study

被引：10
|
作者：
Pratz, Keith W.
DiNardo, Courtney D.
Selleslag, Dominik
Li, Junmin
Yamamoto, Kazuhito
Konopleva, Marina
McDonald, Andrew
Babu, Sunil
Stevens, Don A.
Kantarjian, Hagop M.
Traina, Fabiola
Venditti, Adriano
Mayer, Jiri
Montez, Melissa
Ramsingh, Giridharan
Jin, Huan
Ainsworth, William
Duan, Yinghui
Svensson, Anders Erik
Werner, Michael
Potluri, Jalaja
Jonas, Brian A.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134832
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A
    Pratz, Keith W.
    DiNardo, Courtney D.
    Selleslag, Dominik
    Li, Junmin
    Yamamoto, Kazuhito
    Konopleva, Marina
    Stevens, Don
    Kantarjian, Hagop
    Traina, Fabiola
    Venditti, Adriano
    Mayer, Jiri
    Montez, Melissa
    Jin, Huan
    Duan, Yinghui
    Brackman, Deanna
    Zha, Jiuhong
    Potluri, Jalaja
    Werner, Michael
    Jonas, Brian A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (11) : E416 - E419
  • [2] CYP3A inhibitors and impact of these agents on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine on the VIALE-A study
    Jonas, Brian A.
    Dinardo, Courtney D.
    Fracchiolla, Nicola
    Pristupa, Alexander
    Ishizawa, Kenichi
    Jin, Jie
    Konopleva, Marina
    Ofran, Yishai
    Montesinos, Pau
    Kovacsovics, Tibor
    Jang, Jun-Ho
    Kantarjian, Hagop M.
    Hong, Wan-Jen
    Duan, Yinghui
    Ainsworth, William
    Potluri, Jalaja
    Werner, Michael
    Svensson, Anders Erik
    Pratz, Keith W.
    BLOOD, 2020, 136
  • [3] Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A study
    Jonas, Brian A.
    DiNardo, Courtney
    Fracchiolla, Nicola
    Pristupa, Alexander
    Ishizawa, Kenichi
    Jin, Jie
    Konopleva, Marina
    Ofran, Yishai
    Montesinos, Pau
    Kovacsovics, Tibor
    Jang, Jun-Ho
    Kantarjian, Hagop
    Duan, Yinghui
    Potluri, Jalaja
    Werner, Michael
    Pratz, Keith W.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (11) : E422 - E425
  • [4] Venetoclax in the treatment of acute myeloid leukemia: Beyond VIALE-A
    Gangat, Naseema
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (04) : 515 - 518
  • [5] Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Alary, Anne-Sophie
    Saillard, Colombe
    Hicheri, Yosr
    Mohty, Bilal
    Rey, Jerome
    D'Incan, Evelyne
    Charbonnier, Aude
    Villetard, Ferdinand
    Maisano, Valerio
    Lombardi, Laura
    Ittel, Antoine
    Mozziconacci, Marie-Joelle
    Gelsi-Boyer, Veronique
    Vey, Norbert
    CANCERS, 2022, 14 (08)
  • [6] Outcomes with Real-World Use of Azacitidine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Are Comparable to Long-Term Viale-a Results
    Shah, Zalak
    Boselli, Danielle
    Begley, Stephanie
    Bose, Rupali
    Pang, Yifan
    Sanikommu, Srinivasa Reddy
    Shah, Nilay A.
    Chojecki, Aleksander L.
    Knight, Thomas G.
    Ai, Jing
    Avalos, Belinda
    Copelan, Edward A.
    Grunwald, Michael R.
    Ragon, Brittany Knick
    BLOOD, 2024, 144 : 5194 - 5195
  • [7] Combining azole antifungals with venetoclax plus azacitidine in patients with newly diagnosed acute myeloid leukemia
    Zhong, Xushu
    Wang, Jia
    Dai, Yang
    Huang, Xiaoou
    Liu, Jiazhuo
    Xiang, Bing
    Ma, Hongbing
    HEMATOLOGY, 2024, 29 (01)
  • [8] The propriety of upgrading responses to venetoclax plus azacitidine in newly diagnosed patients with acute myeloid leukemia
    Abbott, Diana
    Cherry, Evan
    Amaya, Maria
    McMahon, Christine
    Schwartz, Marc
    Winters, Amanda
    Schowinsky, Jeffrey
    Jordan, Craig T.
    Smith, Clayton
    Gutman, Jonathan A.
    Pollyea, Daniel A.
    LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1466 - 1473
  • [9] Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia
    Short, Nicholas J.
    Wierzbowska, Agnieszka
    Cluzeau, Thomas
    Laribi, Kamel
    Recher, Christian
    Czyz, Jaroslaw
    Ochrem, Bogdan
    Ades, Lionel
    Gallego-Hernanz, Maria Pilar
    Heiblig, Mael
    Audisio, Ernesta
    Zarzycka, Ewa
    Li, Shuli
    Ferenc, Nicholas
    Yeh, Tammie
    Faller, Douglas V.
    Sedarati, Farhad
    Papayannidis, Cristina
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 458 - 468
  • [10] Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
    Cherry, Evan M.
    Abbott, Diana
    Amaya, Maria
    McMahon, Christine
    Schwartz, Marc
    Rosser, Julie
    Sato, Audrey
    Schowinsky, Jeffrey
    Inguva, Anagha
    Minhajuddin, Mohd
    Pei, Shanshan
    Stevens, Brett
    Winters, Amanda
    Jordan, Craig T.
    Smith, Clayton
    Gutman, Jonathan A.
    Pollyea, Daniel A.
    BLOOD ADVANCES, 2021, 5 (24) : 5565 - 5573
12345